Grown Rogue International (GRUSF) Net Cash Flow (2013 - 2026)
Grown Rogue International (GRUSF) posted quarterly Net Cash Flow of $2.3 million for Q1 2026, down 31.03% year-over-year from $3.4 million in Q1 2025, and up 100.0% quarter-over-quarter from -$8411.9 billion in Q4 2025.
Grown Rogue International (GRUSF) Net Cash Flow (2013 - 2026) Analysis & Trends
Grown Rogue International's Net Cash Flow history runs 14 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 31.03% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at -$8411.9 billion (down 8379756469.61% YoY), while the FY2025 annual figure was $6.5 million, up 524.55% from the prior year.
- Net Cash Flow for Q1 2026 stood at $2.3 million, up from -$8411.9 billion in the prior quarter.
- The five-year high for Net Cash Flow was $4.0 million in Q4 2023, with the low at -$8411.9 billion in Q4 2025.
- The 5-year median for Net Cash Flow is $424841.5 (2022), against an average of -$701.0 billion.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow jumped 157.39% in 2023, then tumbled 1292022235.12% in 2025.
- Grown Rogue International's Net Cash Flow stood at $548914.0 in 2022, then soared by 621.51% to $4.0 million in 2023, then sank by 116.44% to -$651061.9 in 2024, then sank by 1292022235.12% to -$8411.9 billion in 2025, then soared by 100.0% to $2.3 million in 2026.
- Business Quant data shows GRUSF's Net Cash Flow at $2.3 million in Q1 2026, -$8411.9 billion in Q4 2025, and -$199505.2 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Grown Rogue International | 109.32 Mn | 97.78 Mn | 5.37 Mn | -2.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.17 Mn |
| Jun 30, 2026 | -2.17 Mn |
| Mar 31, 2026 | 2.33 Mn |
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | -8,411.87 Bn |
| Dec 31, 2025 | -8,411.87 Bn |
| Jun 30, 2025 | -199,505.15 |
| Jun 30, 2025 | -199,505.15 |
| Mar 31, 2025 | 3.38 Mn |
| Mar 31, 2025 | 3.38 Mn |
| Dec 31, 2024 | -651,061.93 |
| Dec 31, 2024 | -651,061.93 |
| Sep 30, 2024 | -1.41 Mn |
| Sep 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -1.41 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Oct 31, 2023 | 3.96 Mn |
| Oct 31, 2023 | 3.96 Mn |